GlobeNewswire

NuVinci® Cycling Goes Sportive with N380x(TM)

Dela

Introducing a new stepless transmission specifically designed for sportive and cargo bicycle models

AMSTERDAM, NETHERLANDS / CEDAR PARK, TEXAS, July 31, 2017 (GLOBE NEWSWIRE) -- NuVinci Cycling, a division of Fallbrook Technologies Inc., extends its product portfolio by introducing its newest NuVinci Optimized(TM) continuously variable planetary transmission (CVP), the N380x, for the trending sportive applications. The N380x will extend the benefits of the NuVinci® stepless technology by making it available to additional bicycle types, use-cases, and riders.

Recently, the market has seen a significant increase in the amount of newly launched bicycle models that are influenced by sportive design approaches but are being used in a non-performance environment. Typically, sportive bike models are used on forest roads or in parks, with a fitness or a commuting purpose and require a suitable, durable, stepless transmission.

"There are quite a few new types of bike models emerging, both in the eBike and traditional bicycle market. Consumers are looking for sportive products to fit into their usual day-to-day commute and new hybrids between city and mountain bikes are meeting those needs. These hybrid models place different demands on their components, therefore we crafted the N380x - specifically designed to meets the needs of the emerging and more sportive models and more importantly, the riders' needs," says Anne Guethoff, Director of Marketing at NuVinci Cycling.

With its ratio range of 380%, and a maximum continuous input torque of 100Nm in certain conditions, the transmission was developed to offer best-in-class performance for sportive and speed pedelec bicycle types, used under full load acceleration. Plus, the 10*135, 12*142, and 12*148 dropout options enable compatibility with B+ tires for better traction. The N380x comes with all common thru axle adapter types, allowing increased frame stiffness and easy maintenance. The anodized housing and laser engraved product branding ensure a high-end appearance over the long-term. To further ensure great material strength and reliable lasting performance, the component selection includes a forged housing and a freewheel with individual spring pawls. To make it even easier for riders to fully focus on the road conditions, the N380x is available with the Harmony(TM) automatic shifting system. Finally, several internal components in the N380x are upgraded from the N380(TM) transmission. These upgrades increase durability and robustness more than any previously produced NuVinci Optimized transmission.

Scott will be the first OEM to launch a model with N380x at EUROBIKE 2017. "Scott is best known for its sportive models. With our newest project, the E-Silence Evo, we wanted to offer our customers an urban eBike with a sportive appeal. The new N380x fits perfectly with the high-end concept of our bike. With its high performance attributes, it allows us to shift steplessly under full motor power. With the modern design, it is the ideal combination for our sportive target group. In addition, by integrating the shifting system into the eBike controls, we are able to offer a clean handlebar and an intuitive control," summarizes Thomas Berger, Product Manager at Scott.

Besides the trend towards more sportive models, the next wave of eBikes is also looking at inner-city transport solutions. Commercial businesses and consumers alike are seeking ways that enable them to easily transport heavier loads over short distances. As a result, the cargo bike segment is growing fast and requires a durable transmission, which allows shifting under higher loads, even at standstill. With the durability and flexibility of the N380x, it perfectly answers those needs. Therefore, cargo bike riders can enjoy stepless shifting, whether they are freewheeling, shifting under heavy load or waiting at a traffic light.

About NuVinci® Cycling

NuVinci Cycling, a division of Fallbrook Technologies Inc., moves people better through its product portfolio of smooth, stepless, automatic and integrated shifting products for bicycles and eBikes. The NuVinci technology incorporated in continuously variable transmissions (CVT) for bicycles has been providing the best rider experiences since 2006. NuVinci Cycling products include the Nfinity(TM) and Harmony(TM) group sets, utilizing the latest versions of the transmissions and controllers. Products from NuVinci Cycling are available globally in over 100 bicycle brands. For more information, visit www.nuvincicycling.com

About Fallbrook Technologies

Fallbrook Technologies is the inventor of the revolutionary NuVinci® continuously variable planetary (CVP) technology, which enables performance and efficiency improvements for machines that use an engine, pump, motor, or geared transmission system - including urban mobility vehicles, cars and trucks, industrial equipment, and many other applications. Fallbrook has a unique collective development model and community through which NuVinci technology licensees share enhancements, which adds to the value of the technology and accelerates product development. This approach enables forward-looking companies, who wish to create visionary new products with NuVinci technology, to move quickly from concept to market commercialization. Fallbrook is based in Cedar Park near Austin, Texas, USA and holds rights to over 800 patents and patent applications worldwide. For more information, visit www.fallbrooktech.com.

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/64f50f67-7432-4d74-bb04-c408302209de

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/c98b2aab-e944-4c26-83a1-6d7ff47bb504

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/7f16d73c-d411-4c11-a6a9-60ae30cdda7d

Anne Guethoff, Director of Marketing
NuVinci Cycling | a Division of Fallbrook Technologies
+ 49 160 92290159
Anne.Guethoff@nuvincicycling.com

Trammie Anderson, Director of Corporate Marketing
Fallbrook Technologies Inc.
512-519-5194
trammie.anderson@fallbrooktech.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NuVinci Cycling via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Stillfront: Simutronics reclaims publishing services10.12.2018 14:11Pressmeddelande

PRESS RELEASE December 10, 2018 Simutronics reclaims the publishing services for SIEGE: Titan Wars globally except China Simutronics Corp, a studio within Stillfront Group AB, has ended a co-publishing agreement regarding the mobile game SIEGE: Titan Wars with New York based publishing partner Tilting Point. According to a new agreement, Tilting Point will continue to provide publishing services and market the game in China but Simutronics will run the publishing services and marketing globally from the Group going forward. Simutronics is a leading developer of online roleplaying and mobile games such as DragonRealms, GemStone IV and Lara Croft Relic Run, the latter with more than 23 million downloads. Tilting Point is a new-generation games partner that provides top development studios with expert resources, services, and operational support to optimize high quality live games for success. "I am very pleased to continue the partnership with Tilting Point for the Chinese market as this

Stillfront: Simutronics återtar förläggartjänster10.12.2018 14:11Pressmeddelande

PRESSMEDDELANDE 2018-12-10 Simutronics återtar förläggartjänster för SIEGE: Titan Wars globalt med undantag för Kina Simutronics, en studio inom Stillfront Group, har avslutat ett medförläggaravtal avseende mobilspelet SIEGE: Titan Wars med den New York-baserade förläggarpartnern Tilting Point. Enligt ett nytt avtal kommer Tilting Point fortsatt att tillhandahålla förläggartjänster och marknadsföring av spelet i Kina men på global nivå kommer Simutronics att ansvara för förläggartjänster och marknadsföring av spelet från gruppen. Simutronics är en ledande utvecklare av rollspel och mobila spel som till exempel DragonRealms, GemStone IV och Lara Croft Relic Run, den sistnämnda med mer än 23 miljoner nedladdningar. Tilting Point är den nya generationens spelbolagspartner som förser ledande utvecklingsstudios med expertis, tjänster och operationell support för att optimera högkvalitativa livespel framgångsrikt. "Jag är mycket nöjd över det fortsatta partnerskapet med Tilting Point för den

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

Karolinska Development's portfolio company Aprea Therapeutics presents continued positive results from a Phase Ib/II study of APR 2462.12.2018 18:00Pressmeddelande

STOCKHOLM, December 2, 2018. Karolinska Development's portfolio company Aprea Therapeutics today presented positive clinical results for its drug candidate APR 246 at the 2018 American Society of Hematology (ASH) Annual Meeting in San Diego, US. An Overall Response Rate of 95% and a Complete Remission (CR) rate of 70% were achieved in an ongoing Phase I/II combination study of APR 246 and azacitidine (AZA) for the treatment of TP53 mutated Myelodysplastic Syndrome (MDS). No dose-limiting toxicities have been observed. Based on these encouraging data, Aprea intends to progress APR 246 into a Phase III study in the near future. The results presented at the ASH meeting is based on 20 patients with TP53 mutated MDS. The overall response rate was 95%, and 14 (70%) patients achieved a complete remission at data cutoff. These findings were accompanied by a deep molecular remission in the majority of patients as assessed by serial TP53 analysis. No dose-limiting toxicities have been experience

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum